Your browser doesn't support javascript.
loading
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes.
Peiffer, Lukas; Farahpour, Farnoush; Sriram, Ashwin; Spassova, Ivelina; Hoffmann, Daniel; Kubat, Linda; Stoitzner, Patrizia; Gambichler, Thilo; Sucker, Antje; Ugurel, Selma; Schadendorf, Dirk; Becker, Jürgen C.
Afiliação
  • Peiffer L; Deutsches Konsortium Für Translationale Krebsforschung (DKTK), Partner Site Essen, Translational Skin Cancer Research, University of Duisburg-Essen, Universitätsstr. 1, 45141, Essen, Germany.
  • Farahpour F; Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
  • Sriram A; Bioinformatics and Computational Biophysics, University Duisburg-Essen, Essen, Germany.
  • Spassova I; Deutsches Konsortium Für Translationale Krebsforschung (DKTK), Partner Site Essen, Translational Skin Cancer Research, University of Duisburg-Essen, Universitätsstr. 1, 45141, Essen, Germany.
  • Hoffmann D; Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
  • Kubat L; Deutsches Konsortium Für Translationale Krebsforschung (DKTK), Partner Site Essen, Translational Skin Cancer Research, University of Duisburg-Essen, Universitätsstr. 1, 45141, Essen, Germany.
  • Stoitzner P; Bioinformatics and Computational Biophysics, University Duisburg-Essen, Essen, Germany.
  • Gambichler T; Deutsches Konsortium Für Translationale Krebsforschung (DKTK), Partner Site Essen, Translational Skin Cancer Research, University of Duisburg-Essen, Universitätsstr. 1, 45141, Essen, Germany.
  • Sucker A; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Ugurel S; Department of Dermatology, Skin Cancer Center, Ruhr-University Bochum, Bochum, Germany.
  • Schadendorf D; Department of Dermatology, University Hospital of Essen, Essen, Germany.
  • Becker JC; Department of Dermatology, University Hospital of Essen, Essen, Germany.
Cancer Immunol Immunother ; 70(6): 1635-1647, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33275172
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos do Interstício Tumoral / Proteínas Proto-Oncogênicas B-raf / MAP Quinase Quinase 1 / Inibidores de Proteínas Quinases / Reprogramação Celular / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos do Interstício Tumoral / Proteínas Proto-Oncogênicas B-raf / MAP Quinase Quinase 1 / Inibidores de Proteínas Quinases / Reprogramação Celular / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha